Crystal Structures of HLA-A*0201 Complexed with Melan-A/MART-1 26(27L)-35 Peptidomimetics Reveal Conformational Heterogeneity and Highlight Degeneracy of T Cell Recognition
Abstract : There is growing interest in using tumor associated antigens presented by class I major histocompatibility complex (MHC-I) proteins as cancer vaccines. As native peptides are poorly stable in biological fluids, researchers have sought to engineer synthetic peptidomimetics with greater biostability. Here, we demonstrate that antigenic peptidomimetics of the Melan-A/MART-1 26(27L)-35 melanoma antigen adopt strikingly different conformations when bound to MHC-I, highlighting the degeneracy of T cell recognition and revealing the challenges associated with mimicking native peptide conformation.
https://www.hal.inserm.fr/inserm-03349290 Contributor : Nadine GERVOISConnect in order to contact the contributor Submitted on : Monday, September 20, 2021 - 2:08:56 PM Last modification on : Wednesday, April 27, 2022 - 3:50:17 AM Long-term archiving on: : Tuesday, December 21, 2021 - 6:49:28 PM
File
Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed
until : jamais
Céline Douat-Casassus, Oleg Borbulevych, Marion Tarbe, Nadine Gervois, Francine Jotereau, et al.. Crystal Structures of HLA-A*0201 Complexed with Melan-A/MART-1 26(27L)-35 Peptidomimetics Reveal Conformational Heterogeneity and Highlight Degeneracy of T Cell Recognition. Journal of Medicinal Chemistry, American Chemical Society, 2010, 53 (19), pp.7061-7066. ⟨10.1021/jm100683p⟩. ⟨inserm-03349290⟩